New York, NY, July 16, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that its video e-commerce business has partnered with over 50 influencers, resulting in continued rapid sales growth. By leveraging these key partnerships, Fresh2's video e-commerce business is rapidly expanding its market presence in the e-commerce sector. (Screenshot of some Company's venu ...

New York, NY, July 16, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that its video e-commerce business has partnered with over 50 influencers, resulting in continued rapid sales growth. By leveraging these key partnerships, Fresh2's video e-commerce business is rapidly expanding its market presence in the e-commerce sector. (Screenshot of some Company’s ven ...

New York, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that it will change the ratio of its American depositary shares (“ADSs”) to its Class A ordinary shares from one (1) ADS representing twenty (20) Class A ordinary shares to one (1) ADS representing two hundred (200) Class A ordinary shares (the “ADS Ratio Change”). The ADS Ratio Change is ex ...

New York, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that it will change the ratio of its American depositary shares ("ADSs") to its Class A ordinary shares from one (1) ADS representing twenty (20) Class A ordinary shares to one (1) ADS representing two hundred (200) Class A ordinary shares (the "ADS Ratio Change"). The ADS Ratio Change is exp ...

New York, NY, June 24, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that it plans to change the ratio of its American depositary shares (“ADSs”) to its Class A ordinary shares from one (1) ADS representing twenty (20) Class A ordinary shares to one (1) ADS representing two hundred (200) Class A ordinary shares (the “ADS Ratio Change”). The ADS Ratio Change i ...

New York, NY, June 24, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that it plans to change the ratio of its American depositary shares (“ADSs”) to its Class A ordinary shares from one (1) ADS representing twenty (20) Class A ordinary shares to one (1) ADS representing two hundred (200) Class A ordinary shares (the “ADS Ratio Change”). The ADS Ratio Change i ...

Fresh2 Group (NASDAQ:FRES) stock is heading higher on Tuesday alongside heavy pre-market trading of the biotechnology company’s shares.This has more than 5.6 million shares of FRES stock changing hands as of this writing. That’s a massive surge in trading volume compared to the company’s shares average of about 96,000 shares.Investors will note this movement comes without any news from Fresh2 Group. That includes a lack of press releases or filings. There’s also no analyst coverage that would cause shares o ...

公司财务状况及资金需求 - 公司自成立以来每年都亏损，预计将来也会继续亏损[25] - 公司需要大量资金支持业务运营，如果无法以可接受的条件筹集足够资本，业务、财务状况和前景可能会受到重大不利影响[26] - 公司已签署了几份投资协议，以筹集资金支持业务运营[27] - 公司完成了向机构投资者出售股票的交易，获得了大约300万美元的投资[28] COVID-19疫情影响 - 公司在中国和美国的业务受到COVID-19疫情的不利影响，可能会继续受到影响[32] - 上海办公室因COVID-19复苏政策而暂停运营，导致收入确认延迟[33] 市场风险及竞争压力 - 不利的地缘政治事件或市场动荡可能影响公司的销售额、利润、现金流和未来增长[34] - 公司可能面临来自其他公司或机构开发和推出新型或改进的早期癌症筛查和检测方法的竞争，可能使CDA技术变得不那么具竞争力或过时[49] 技术及知识产权风险 - 公司依赖技术，任何网络安全事件或技术中断可能对业务产生负面影响[39] - 未来专利申请可能不会导致授予专利，竞争对手可能设计产品绕过专利技术[60] - 知识产权保护不足可能导致直接或间接竞争，影响公司竞争地位和业务[61] 业务运营风险 - 公司可能面临诉讼和其他索赔，可能无法成功辩护[42] - 公司未购买产品责任或专业责任保险，可能面临产品责任索赔，这可能超出公司资源承受范围[54] - 公司可能面临第三方体检中心提供的服务存在缺陷的责任索赔，可能损害声誉并对运营结果产生不利影响[55] 市场拓展及产品发展 - 公司计划在2024年第一季度获得NMPA的CDA设备注册证书，以进入中国医院市场[48] - 公司计划在2023年第二季度晚些时候在选定的医院开始对肺癌辅助诊断实用医疗器械进行临床试验[90] 税务及法律风险 - 公司可能被认定为中国居民企业，导致不利的税务后果[130] - 通过间接转让股权可能面临税务风险，需支付10%的税率[131] - 中国政府对货币兑换实施控制，可能影响现金利用和投资价值[132] 股票交易及投资风险 - 公司ADSs若被摘牌，可能导致股价下跌和投资者交易受限[145] - 公司股权结构可能限制股东影响力，阻碍潜在控制权变更[147] - 证券分析师不发布关于公司的研究或负面调整评级可能导致ADSs市场价格下跌[149] 技术及产品优势 - 公司的CDA技术已在多项回顾性验证研究中显示出高敏感性和特异性，能够检测26种癌症类型的风险[170] - 公司已建立了一个包含超过280,095份血样的测试数据库，其中包括商业CDA测试和研究研究的样本[171] - 公司自主设计的CDA设备使用多参数传感器系统进行癌症筛查和检测[196]

AnPac Bio-Medical Science Co., Ltd. (ANPC) Q4 2020 Results Conference Call April 30, 2021 8:30 AM ET Company Participants Phil Case - IR Dr. Chris Yu - Chairman and CEO Edwards Tang - CFO Conference Call Participants John Vandermosten - Zacks SCR Operator Good morning, everyone. Thank you for standing by. [Operator Instructions] The call is being recorded. Phil Case This is Phil Case, Investor Relations for the Company. Welcome to AnPac Bio’s Fiscal Year 2020 Financial Results Conference Call. During today’ ...